SUDARSCHEM Sudarshan Chemical Industries Q2 FY26 results (Jul–Sep 2025) and concall
Sudarshan Chemical Industries reported a challenging Q2 FY26, marked by flat sales and flattish EBITDA for its legacy business, and a significant drop in gross profit margin for the domestic segment. The acquired group also faced soft demand and high customer inventories, leading to a downward revision of its FY26 EBITDA guidance to €25-30 million. Despite these temporary demand issues and high fixed costs, management expressed confidence in a strong Q4 recovery driven by customer inventory depletion and ongoing integration efforts, maintaining its long-term growth outlook.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 243.0%, net profit down 36.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 696 | 666 | 1,349 | 2,507 | 2,387 +243% |
| EBITDA | 94 | 79 | 127 | 192 | 132 +40% |
| Net profit | 30 | 1 | 0 | 55 | 19 −37% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
